T. Shirin et al., Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh, J HEALTH PO, 18(3), 2000, pp. 145-150
This cross-sectional study investigated the prevalence and risk factors of
hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficienc
y virus (HIV) infections among 266 drug users attending a drug-addiction tr
eatment centre in Dhaka, Bangladesh, from November 1996 to April 1997. Of t
he 266 addicts, 129 were injectable drug users (IDUs), and 137 were non-inj
ectable drug users (non-IDUs). The seroprevalences of hepatitis B virus sur
face antigen (HBsAg), anti-HBc, anti-HBs, and anti-HCV antibodies among the
IDUs were 8 (6.2%),41 (31.8%), 15 (11.6%), and 32 (24.8%), and among the n
on-IDUs were 6 (4.4%), 33 (24.1%), 9 (6.6%), and 8 (5.8%) respectively. Non
e of the drug users were positive for anti-HIV antibody. Although the preva
lence of HBV infection did not significantly differ between the IDUs and th
e non-IDUs, the prevalence of HCV infection was significantly higher among
the IDUs. Among the IDUs, the prevalence of both HBV and HCV infections was
associated with sharing of needles and longer duration of injectable drugs
used. The seroprevalence of HBV infection in both IDUs and non-IDUs was si
gnificantly higher among those who had a history of extramarital and premar
ital sex. The prevalence of HCV infection was not associated with sexual pr
omiscuity. There was no association between the seroprevalence of HBV and H
CV infections and age. Active preventive programmes focusing on educational
campaigns among the youths against substance abuse should be undertaken.